Pharmaceutical company names Dr. John McHutchison CEO, president — 4 insights

Assembly Biosciences named former Gilead Sciences Chief Scientific Officer John McHutchison, MD, its new president and CEO, succeeding company co-founder Derek Small.

What you should know:

1. Dr. McHutchison is a gastroenterologist and a researcher. He comes to Assembly after a nine-year tenure at Gilead Sciences, where he led new drug development efforts.

2. Dr. McHutchison is a noted researcher, with most of his work focusing on hepatitis B and hepatitis C.

3. Mr. Small helped establish the company in 2014. He'll return to his venture creation firm, Luson Bioventures, but will continue to serve on Assembly Biosciences' board.

4. Assembly Biosciences' work centers on hepatitis B and diseases associated with the microbiome.

More articles on surgery centers: 
$12M ASC completed in North Dakota
Joint-venture ASC opens location near UK HealthCare — 5 insights
Minnesota hospital planning ASC  

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers